Vitamin D Not Associated With Risk For Less Common Cancers, Study Finds
ASCO Recommends Aromatase Inhibitors As Adjuvant For Some Breast Cancer
Half Of Women Complete Full Hormone Therapy Regimen
Surveillance Colonoscopy Cost-Effective For High-Risk
Surveillance Treatment Option For Low-Risk Prostate Cancer
Toxicity, Non-Cancer Deaths Increase With Combo Therapy
Time Spent Sitting Associated With Total Mortality, Study Finds
Cancer Mortality Rate Down 1.3 Percent, ACS Report Finds
NCI-Approved Clinical Trials
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure - Alec Kimmelman announced as next CEO and Dean of NYU Langone Health
